NE
Neuland Laboratories Limited
NEULANDLAB.BO · BSE
₹22,620.00 -3.02% (-₹705.00)
1M -0.88%
Market Cap ₹294.3B
P/E Ratio 59.13x
Div. Yield 0.15%
ROE 28.49%
Bulios Fair Price
₹20,917
7.5% downside
Current Price
₹22,620
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NEULANDLAB.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
0 /100
Expensive P/E 59.13x
P/B 15.70x
EV/EBITDA 37.08x
Growth
96 /100
Growing EPS growth 59.74%
Book val. growth 21.96%
Rev. growth 15.82%
Profitability
70 /100
Strong Gross margin 49.97%
FCF margin 8.75%
Net margin 20.99%
Quality
100 /100
Excellent ROE 28.49%
ROIC N/A
Asset turnover N/A
Debt
100 /100
Low Debt/Equity 0.00x
Net debt/EBITDA 0.00x
Int. coverage 26.41x
Stability
45 /100
Moderate Beta -0.32x
Profitable years 6
Rev. volatility 19.50%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NEULANDLAB.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Davuluri Saharsh Rao
Employees
1,643
Headquarters
Hyderabad
Upcoming events
10 NOV
Earnings
Upcoming earnings report